Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-randomized, Multicenter, Confirmatory Study by Intrathecal Administration of KP-100IT in Subjects With Acute Spinal Cord Injury

NCT04475224 is registered in ClinicalTrials.gov with Kringle Pharma, Inc. as lead sponsor.

NCT NCT04475224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04475224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-randomized, Multicenter, Confirmatory Study by Intrathecal Administration of KP-100IT in Subjects With Acute Spinal Cord Injury
Lead sponsor
Kringle Pharma, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
July 13, 2020
Completion date
June 30, 2023
Enrollment
25 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute spinal cord injury